No Result
View All Result
  • Home
  • Stock Watchlist
  • Stock Analyst News
  • Earnings News
  • Insider Trades
  • Dividend Stocks
Subscribe Now
  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports
No Result
View All Result
HOME MARKET SECTORS STOCK BUYS INSIDER TRADES DIVIDEND STOCKS
     BACK TO MENU Technology Health Finance Consumer Commercial Services Electronic Communications Transportation Utilities Minerals Other Sectors Electric Vehicles Pot Stock 5G Stock Crypto
cryptodailypress.com
No Result
View All Result
No Result
View All Result

4 Top Dividend Stocks to Review (Oct 2nd)

by Staff Editor
Oct 02, 2024
in Dividend 

Sponsor

Don't Buy Another Stock Until You See This [Full Story >>]


Here's the list:

AT&T Inc.

Price Target: $24.00

Paragraph 1: AT&T Inc. is the second largest wireless service provider in North America and one of the world's leading communications service carriers. Through its subsidiaries and affiliates, the company offers a wide range of communication and business solutions that include wireless, local exchange, long-distance, data/broadband and Internet, video, managed networking, wholesale and cloud-based services.

Paragraph 2: With assets like HBO, CNN and TNT, AT&T's acquisition of Time Warner has created new kinds of online videos and opened up avenues for targeted advertisements. The company is also focusing on streaming services with AT&T TV and HBO Max. This is likely to create other avenues to monetize content as it expands 5G coverage across the country.

Market Cap: $158.68B
Last Dividend Amount: $0.28
Expected Ex-Dividend Date: Jul 10 2024
Expected Payment Date: Aug 01 2024
Expected Dividend & Yield: 5.02%

Click for chart >> 



AbbVie Inc.

Price Target: $204.00

Paragraph 1: AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi and Rinvoq position it well for long-term growth.

Paragraph 2: AbbVie came into existence after Abbott Laboratories divested its pharmaceutical division. AbbVie enjoys leadership positions in key therapeutic areas including immunology, hematologic oncology, neuroscience, aesthetics, eye care and womens' health. Humira is approved for several autoimmune diseases like rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis, Crohn's disease and others. Imbruvica became part of the company's portfolio following the Pharmacyclics acquisition. Other key drugs include Venclexta, Botox Cosmetic, Botox Therapeutics, Vraylar, Skyrizi and Rinvoq.

Market Cap: $347.90B
Last Dividend Amount: $1.55
Expected Ex-Dividend Date: Oct 15 2024
Expected Payment Date: Nov 15 2024
Expected Dividend & Yield: 3.15%

Click for chart >> 



Hormel Foods Corporation

Price Target: $33.25

Paragraph 1: Hormel Foods Corporation is a leading manufacturer as well as marketer of various meat and food products in the U.S. and international markets. Its brands include Planters(TM), SKIPPY(TM), SPAM(TM), Hormel(TM), Natural Choice(TM), Applegate(TM), Justin's(TM), Wholly(TM), Hormel(TM), Black Label(TM), Columbus(TM), Jennie-O(TM) and more than 30 other brands.

Market Cap: $17.36B
Last Dividend Amount: $0.28
Expected Ex-Dividend Date: Oct 15 2024
Expected Payment Date: Nov 15 2024
Expected Dividend & Yield: 3.57%

Click for chart >> 



Abbott Laboratories

Price Target: $123.00

Paragraph 1: Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products.

Paragraph 2: Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.

Market Cap: $197.58B
Last Dividend Amount: $0.55
Expected Ex-Dividend Date: Oct 15 2024
Expected Payment Date: Nov 15 2024
Expected Dividend & Yield: 1.94%

Click for chart >> 


YOU MIGHT WANT TO WATCH THIS NEXT

The #1 Energy Passive Income Investment for 2024

It's not a stock, bond or private company...

But this little-known alternative investment could hand you BIG MONTHLY INCOME from the oil and gas surge in 2024.

CLICK HERE TO FIND OUT WHAT IT IS 


Tags: Dividend 

Related Posts

From Shrinkflation to Economic Collapse: Is a Financial Storm Brewing?

Oct 13, 2024

The Week Ahead: Earnings Season Kicks Off and Retail Sales in Focus

Oct 13, 2024
Dividend 

4 Stocks Up 30%+ in 5 Days: EV, Lithium, and Tech Leaders

Oct 09, 2024
UP Fintech Holding Limited stock TIGR TIGR price target Financial Services stock watchlist Financial Services stocks 

4 Soaring Stocks Up Over 46% in 5 Days

Oct 04, 2024
Dividend 

3 Dividend Stocks Up Over 30% in the Last Week

Oct 04, 2024

Massive "Backdoor" Pre-IPO Play in Musk's $100 Billion Starlink?

Oct 03, 2024
Next Post
Canadian regulator rejects Enbridge plan to contract oil pipeline space

Canadian regulator rejects Enbridge plan to contract oil pipeline space

Nvidia’s DLSS has come to Linux gaming (but not the Steam Deck obviously)

No Result
View All Result

Screener data might be 15 minutes delayed from the real time.

  • Newsletters
  • Advertise with Us
  • About Us
  • Feedback/Contact Us
  • Email Notice, Data Use and DMCA
  • Privacy Policy
  • Terms of Use and Disclaimer
  • 17B List of Disclosures
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This site contains articles and videos are offered for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation or be relied upon as personalized investment advice. We are a financial publisher. We are not financial advisors and cannot give personalized advice. There is a risk of loss in all trading, and you may lose some or all of your original investment. Results presented are not typical. Never make any investment or trade with our first consulting with your investment advisor and after doing your own due diligence. This webpage and website is protected by copyright laws of the United states and international treaties.

©2021 Sandpiper Marketing Group
PO Box 407. Mt. Mourne, NC 28123-0407

  • Home
  • Market Sectors
    • Technology
    • Health
    • Finance
    • Consumer
    • Commercial Services
    • Electronic
    • Communications
    • Transportation
    • Utilities
    • Minerals
    • Other Sectors
    • Electric Vehicles
    • Pot Stock
    • 5G Stock
    • Crypto
  • Stock Buys
    • Strong Buys
    • Insider Buys
  • Insider Trades
  • Dividend Stocks
  • Event Calendars
    • Earnings and Dividend
    • IPO
  • Special Reports

©2021 Sandpiper Marketing Group

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In